CD68 and MCP-1/CCR2 expression of initial biopsies reflect the outcomes of membranous nephropathy

Keiichi Yoshimoto1, Takashi Wada, Kengo Furuichi

  • 1Department of Gastroenterology and Nephrology and Division of Blood Purification, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan. dialysis@medf.m.kanazawa-u.ac.jp

Nephron. Clinical Practice
|September 14, 2004
PubMed
Abstract

Insights

Interstitial CD68-positive cells and MCP-1/CCR2 expression indicate a higher risk of end-stage renal failure (ESRF) in idiopathic membranous nephropathy (IMN) patients. This finding aids in predicting long-term outcomes for IMN.

Area of Science:

  • Nephrology
  • Pathology
  • Immunology

Background:

  • Idiopathic membranous nephropathy (IMN) presents a variable prognosis.
  • Predictive factors for long-term outcomes in IMN are not well-defined.

Purpose of the Study:

  • To identify prognostic factors for end-stage renal failure (ESRF) in idiopathic membranous nephropathy (IMN).
  • To analyze initial renal biopsy findings associated with long-term outcomes in IMN patients.

Main Methods:

  • Retrospective study of 30 IMN patients followed for at least 5 years or until ESRF.
  • Analysis of renal biopsies for tubulointerstitial lesions, foam cells, CD68, MCP-1, CCR2, and alpha-smooth muscle actin expression.

Main Results:

  • Patients developing ESRF showed increased glomerular segmental sclerosis, interstitial MCP-1, CCR2/CD68-positive cells, and foam cells.
  • Interstitial CD68-positive cells (≥10/field) were an independent risk factor for ESRF (HR 4.096, p < 0.001).

Conclusions:

  • Interstitial infiltration of CD68-positive cells and MCP-1/CCR2 expression are significant indicators of ESRF in IMN.
  • These markers can help predict the long-term prognosis of IMN.

Related Concept Videos